Comorbid Dementia and Cancer Therapy Decision-Making: A Scoping Review.
Sean N HalpinGabriel AlainAaron SeamanErin E StevensHui ZhaoMackenzie E FowlerQiuyang ZhangTamara J CadetMinzhi YeJessica L Krok-SchoenPublished in: Journal of applied gerontology : the official journal of the Southern Gerontological Society (2024)
Comorbid dementia complicates cancer therapy decision-making in older adults. We aimed to synthesize the recent literature (<5 years) on the challenges associated with cancer therapy decision-making among older people living with dementia (PLWD) and their caregivers. Of the 20,763 references, 8767 had their title and abstract screened, and eight met the inclusion criteria. Six studies were qualitative, one study employed mixed methods, and one study was quasi-experimental. Most studies were conducted in the UK (89%) and reported homogeneity in race and geography. Breast (56%) and prostate (45%) were the most frequent reported cancers. Five studies (56%) reported multiple types of dementia, with two (22%) indicating stages. The studies indicated that communication between patients, caregivers, and clinical teams might alleviate stress caused by worsening health prospects and potential ethical concerns. Information from this review can lead to better-informed, patient-centered treatment decision processes among older PLWD and cancer, their caregivers, and clinicians.
Keyphrases
- cancer therapy
- decision making
- mild cognitive impairment
- palliative care
- drug delivery
- cognitive impairment
- case control
- end stage renal disease
- healthcare
- systematic review
- prostate cancer
- public health
- ejection fraction
- chronic kidney disease
- randomized controlled trial
- squamous cell carcinoma
- physical activity
- peritoneal dialysis
- tyrosine kinase
- clinical trial
- prognostic factors
- human health
- young adults
- squamous cell
- study protocol
- climate change
- cross sectional
- social media
- combination therapy
- functional connectivity
- patient reported outcomes
- resting state